SOHO 2022 Tenth Annual Meeting

 

Lymphoma
10:00

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Biology and Treatment of LGL Leukemia

FEATURING Thomas Loughran
  • 156 views
  • October 17, 2022
  • 1
10:35

SOHO 2022 Tenth Annual Meeting

SOHO 2022 Next Questions: Hodgkin Lymphoma

FEATURING Nancy Bartlett
  • 230 views
  • October 14, 2022
10:19

SOHO 2022 Tenth Annual Meeting

Next Questions: Mantle Cell Lymphoma

FEATURING Kami Maddocks
  • 61 views
  • October 14, 2022
11:27

SOHO 2022 Tenth Annual Meeting

SOHO 2022 Next Questions: T-Cell Lymphoma

FEATURING Swaminathan Iyer
  • 36 views
  • October 14, 2022
  • 1
12:37

SOHO 2022 Tenth Annual Meeting

SOHO 2022 Next Questions: Follicular Lymphoma

FEATURING Gilles Salles
  • 71 views
  • October 14, 2022
15:31

SOHO 2022 Tenth Annual Meeting

SOHO 2022: What's Next in Aggressive B-Cell Lymphoma?

FEATURING Laurie H. Sehn
  • 449 views
  • October 14, 2022
10:34

SOHO 2022 Tenth Annual Meeting

SOHO 2022 Next Questions: Cellular Therapy

FEATURING Krishna Komanduri
  • 184 views
  • October 14, 2022
16:19

SOHO 2022 Tenth Annual Meeting

SOHO 2022 DEBATE: CAR T-Cell vs. AUTO HCT for R/R DLBCL - Pro AUTO HCT

FEATURING Craig Sauter
  • 21 views
  • October 14, 2022
12:05

SOHO 2022 Tenth Annual Meeting

SOHO 2022 DEBATE: CAR T-Cell vs. AUTO HCT for R/R DLBCL - Pro CAR T-Cell

FEATURING Manali Kamdar
  • 41 views
  • October 14, 2022
08:34

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Camidanlumab Tesirine - Updated Efficacy and Safety in Patients With R/R cHL

FEATURING Alex Herrera
  • 20 views
  • October 14, 2022
16:42

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Treating Hodgkin Lymphoma After Brentuximab Vedotin and Anti-PD1 Failure

FEATURING Alex Herrera
  • 141 views
  • October 14, 2022
16:18

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Sequencing Novel Agents in Frontline and Second-Line Treatment of Hodgkin Lymphoma

FEATURING Alison Moskowitz
  • 227 views
  • October 14, 2022
  • 1
07:04

SOHO 2022 Tenth Annual Meeting

Phase 1/2 BRUIN Study - Updated Results on Pirtobrutinib in Previously Treated MCL

FEATURING Jonathon Cohen
  • 110 views
  • October 14, 2022
19:47

SOHO 2022 Tenth Annual Meeting

Emerging Treatment Options for MCL

FEATURING Jia Ruan
  • 48 views
  • October 14, 2022
13:18

SOHO 2022 Tenth Annual Meeting

Immunotherapeutic Options for Patients With MCL Who Progress on BTK Inhibitors

FEATURING Jonathon Cohen
  • 71 views
  • October 14, 2022
  • 1
14:31

Tycel Phillips

The Role of Targeted Therapies in Frontline Treatment of MCL

  • 121 views
  • October 14, 2022
16:52

SOHO 2022 Tenth Annual Meeting

Is it Time to Recognize the Biological Heterogeneity of MCL?

FEATURING Andre Goy
  • 73 views
  • October 14, 2022
08:47

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Cost-Effectiveness of Polatuzumab Vedotin in Previously Untreated DLBCL

FEATURING John Burke
  • 19 views
  • October 14, 2022
08:56

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Results from POLARIX, a Phase III Study of Pola-R-CHP vs. R-CHOP Therapy in Patients With Previously Untreated DLBCL

FEATURING Christopher Flowers
  • 265 views
  • October 14, 2022
  • 1
13:55

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Managing the Elderly Patient With Aggressive B-cell Lymphoma in The Modern Era

FEATURING Catherine Thieblemont
  • 21 views
  • October 14, 2022
11:32

SOHO 2022 Tenth Annual Meeting

SOHO 2022: CNS Prophylaxis in DLBCL

FEATURING Victor Orellana-Noia
  • 41 views
  • October 14, 2022
14:57

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Treatment of Aggressive B-cell Lymphoma Post-CAR T-Cell Therapy

FEATURING Grzegorz Nowakowski
  • 16 views
  • October 14, 2022
15:19

SOHO 2022 Tenth Annual Meeting

SOHO 2022: The Emerging Potential of Bispecific Antibodies as Monotherapy and in Combination for Aggressive B-Cell Lymphoma

FEATURING Michael Dickinson
  • 104 views
  • October 14, 2022
  • 1
15:03

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Choosing CAR T-Cell Therapy vs. ASCT in R/R Aggressive B-cell Lymphoma

FEATURING Manali Kamdar
  • 149 views
  • October 14, 2022
  • 1
15:33

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Has R-CHOP Really Been Replaced as Initial Therapy of DLBCL?

FEATURING Jonathan Friedberg
  • 986 views
  • October 14, 2022
05:56

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Pivotal Results From a Phase I/II Study of Mosunetuzumab Monotherapy for Patients With R/R FL Who Have Received ≥2 Prior Lines of Therapy

FEATURING Loretta Nastoupil
  • 34 views
  • October 14, 2022
19:37

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Using Biology to Determine Type and Duration of Treatment in Waldenstrom Macroglobulinemia

FEATURING Prashant Kapoor
  • 11 views
  • October 14, 2022
15:04

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Future Role of Bispecific Antibodies in the Treatment of Follicular Lymphoma

FEATURING Elizabeth Budde
  • 25 views
  • October 14, 2022
15:37

SOHO 2022 Tenth Annual Meeting

SOHO 2022: What Is the Role of Transplantation for FL in the Era of CAR T-cell Therapy?

FEATURING Mehdi Hamadani
  • 11 views
  • October 14, 2022
15:08

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Sequencing Therapy in Indolent Lymphoma - Treatment Choices

FEATURING Loretta Nastoupil
  • 269 views
  • October 14, 2022
  • 1
10:04

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Correlation of TRBC1 by Flow Cytometry With Molecular T-Cell Receptor Clonality for the Investigation of T-Cell Lymphocytosis

FEATURING Tania Dexter
  • 8 views
  • October 14, 2022
14:13

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Advances in the Treatment of NK/T Cell Lymphoma

FEATURING Won Seog Kim
  • 19 views
  • October 14, 2022
16:35

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Integrating Novel Agents Into the Management of Cutaneous T-cell Lymphoma

FEATURING Pamela Allen
  • 65 views
  • October 14, 2022
  • 2
15:40

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Novel Treatment Approaches in Relapsed/Refractory PTCL

FEATURING Matthew Lunning
  • 6 views
  • October 14, 2022
15:49

SOHO 2022 Tenth Annual Meeting

SOHO 2022: The Next Rational Therapeutic Regimen in Newly Diagnosed PTCL

FEATURING Neha Mehta-Shah
  • 18 views
  • October 14, 2022
14:21

SOHO 2022 Tenth Annual Meeting

SOHO 2022: From Bench to Bedside - A Translational Scientist's Perspective on How to Transform PTCL Outcome

FEATURING Francisco Vega
  • 12 views
  • October 14, 2022
21:46

SOHO 2022 Tenth Annual Meeting

SOHO 2022: CAR T-Cells in Indolent B-Cell Lymphomas

FEATURING Jeremy Abramson
  • 81 views
  • October 13, 2022
  • 1
18:24

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Challenging Cases in Rare T-Cell Lymphomas

FEATURING Stefan Barta
  • 16 views
  • October 13, 2022
11:16

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Basis for Targeting the Microenvironment in Hodgkin Lymphoma

FEATURING Christian Steidl
  • 70 views
  • October 13, 2022
11:27

SOHO 2022 Tenth Annual Meeting

SOHO 2022: CAR T-Cell Therapy in Hodgkin Lymphoma

FEATURING Carlos Ramos
  • 15 views
  • October 13, 2022
13:22

SOHO 2022 Tenth Annual Meeting

SOHO 2022: The Next Generation of Novel Agents in Development for Aggressive B-Cell Lymphoma

FEATURING Jason Westin
  • 238 views
  • October 13, 2022
  • 5